Red Light Therapy for Eyebrow Growth

Thinning eyebrows are one of the most common cosmetic concerns people bring to dermatologists. Whether caused by over-plucking, ageing, thyroid dysfunction, alopecia areata, or simply genetics, sparse brows can significantly affect facial appearance and self-confidence. The conventional options — microblading, brow serums containing prostaglandin analogues, and topical minoxidil — each carry drawbacks ranging from cost and maintenance to side effects.

Red light therapy has gained attention as a potential non-invasive approach to stimulating eyebrow regrowth. But it is important to be direct: there are no published clinical trials specifically examining red light therapy for eyebrow hair. What we have is a well-established body of evidence showing that photobiomodulation promotes hair growth on the scalp, combined with a reasonable biological rationale for why those mechanisms should apply to eyebrow follicles.

This page examines that evidence, explains the underlying biology, and provides a realistic assessment of what you can and cannot expect.

The biology of eyebrow hair

Eyebrow hairs are terminal hairs — thicker and more pigmented than the vellus hairs that cover most of the body. They follow the same growth cycle as scalp hair, but with one critical difference: the anagen (active growth) phase for eyebrow hair lasts only about four months, compared with two to six years for scalp hair.

This shorter anagen phase is why eyebrow hairs are naturally shorter than scalp hairs. It also means the window of opportunity for any growth-stimulating intervention is narrower.

The eyebrow hair cycle consists of three phases:

Anagen (growth phase) — Lasts approximately four months. The hair follicle is actively producing the hair shaft. About 80 to 90 per cent of eyebrow hairs are in this phase at any given time.
Catagen (transition phase) — Lasts two to three weeks. The follicle begins to shrink and detaches from the dermal papilla.
Telogen (resting phase) — Lasts approximately three months. The old hair remains in the follicle but is no longer growing. Eventually, a new anagen hair pushes it out.

Any therapy that aims to improve eyebrow growth must either extend the anagen phase, increase the proportion of follicles in anagen, or stimulate miniaturised follicles to produce thicker terminal hairs.

How red light therapy promotes hair growth

The evidence for red light therapy and hair growth comes primarily from scalp studies, particularly in androgenetic alopecia. The mechanisms are well characterised and biologically relevant to any hair follicle, including those in the eyebrow region.

Mitochondrial stimulation via cytochrome c oxidase

The primary mechanism of photobiomodulation involves the absorption of red and near-infrared photons by cytochrome c oxidase, a chromophore within the mitochondrial electron transport chain. This absorption increases ATP production, enhances cellular metabolism, and triggers downstream signalling cascades that promote cell proliferation.

In hair follicles, this translates to increased activity of dermal papilla cells — the signalling centre that controls the hair growth cycle. Kim et al. (2017) demonstrated that 660nm light at 3 J/cm² significantly increased the proliferation of human dermal papilla cells in vitro and upregulated growth factors including hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) (Lasers in Medical Science, 32(9), 2085-2093).

Shifting follicles from telogen to anagen

Lanzafame et al. (2014) conducted a double-blind, sham-controlled trial of 655nm red light therapy for androgenetic alopecia. After 16 weeks of treatment, the active group showed a 39 per cent increase in hair count compared with the sham group (Lasers in Surgery and Medicine, 46(8), 601-607).

The proposed mechanism is that red light stimulates telogen follicles to re-enter anagen prematurely, effectively shortening the resting phase and increasing the number of actively growing hairs at any given time.

Increased blood flow

Red light therapy promotes the release of nitric oxide from endothelial cells and haemoglobin, causing local vasodilation. This increases blood flow to the hair follicle, improving the delivery of oxygen and nutrients to the dermal papilla.

Eyebrow follicles, like scalp follicles, depend on an adequate blood supply. The supraorbital and supratrochlear arteries supply the eyebrow region. Any increase in local blood flow could theoretically support follicle function.

Anti-inflammatory effects

Chronic low-grade inflammation around hair follicles is increasingly recognised as a contributor to hair loss. Red light therapy reduces pro-inflammatory cytokines including TNF-alpha and IL-6 whilst increasing anti-inflammatory mediators (Hamblin, 2017, AIMS Biophysics, 4(3), 337-361).

For conditions like alopecia areata — an autoimmune condition that can target eyebrow hair — this anti-inflammatory effect may be particularly relevant.

Can we extrapolate from scalp to eyebrows?

The biological mechanisms described above are not specific to scalp follicles. Cytochrome c oxidase is present in the mitochondria of all human cells, including eyebrow dermal papilla cells. The hair growth cycle is fundamentally the same regardless of body location.

However, there are important caveats:

The shorter anagen phase may limit results. Even if red light therapy successfully extends anagen, the ceiling for eyebrow hair growth is lower than for scalp hair. You will not grow significantly longer eyebrow hairs — but you may grow more of them simultaneously.

The cause of eyebrow loss matters. Red light therapy is most likely to help when thinning is caused by factors that are responsive to increased cellular metabolism and blood flow — such as ageing, over-plucking damage, or telogen effluvium. It is less likely to help when the cause is scarring (cicatricial) alopecia, where follicles have been permanently destroyed.

No specific dosing data exists for eyebrow treatment. The optimal parameters established for scalp hair growth may not translate directly, given the different follicle density and skin thickness in the brow area.

What wavelengths to use

Based on the scalp hair growth literature, two wavelengths have the strongest evidence:

660nm (red) — This is the wavelength used in the majority of successful hair growth trials. It corresponds to a peak absorption wavelength of cytochrome c oxidase and penetrates approximately 8 to 10mm into tissue — more than sufficient to reach eyebrow follicles, which sit 1 to 2mm below the skin surface.

850nm (near-infrared) — Penetrates deeper and has additional anti-inflammatory effects. Less studied specifically for hair growth but may complement red light by improving blood flow and reducing perifollicular inflammation.

For eyebrow treatment specifically, 660nm is the logical first choice. The target structures are shallow, and this is the wavelength with the most hair growth evidence behind it.

Suggested protocol

There are no eyebrow-specific protocols in the literature, so the following is extrapolated from scalp hair growth studies:

Wavelength: 630 to 660nm (red)
Power density: 10 to 40 mW/cm²
Dose per session: 3 to 6 J/cm² (approximately 2 to 5 minutes depending on device output)
Frequency: 3 to 5 times per week
Duration: Minimum 12 to 16 weeks before assessing results
Device placement: 2 to 5cm from the brow area

Eye safety

This is the most important consideration for eyebrow treatment. The eyebrow region sits directly above the eye. Even with eyes closed, red and near-infrared light can penetrate the eyelid.

Always wear appropriate eye protection when treating the eyebrow area. This means certified light therapy goggles or safety glasses that block the relevant wavelengths — not simply closing your eyes. Standard sunglasses are not sufficient.

Some LED face masks provide integrated eye shielding. If using a handheld device or panel, you must provide your own eye protection.

Which devices suit eyebrow treatment?

Given the small treatment area, a full panel is unnecessary. The most practical options include:

LED face masks — Many cover the forehead and brow area. Look for masks with 630 to 660nm LEDs. Ensure adequate eye protection is built in.
Handheld wands — Allow precise targeting of the brow area. Devices like the Hooga HG24 or similar targeted wands are suitable.
Small tabletop panels — Can be used at close range for targeted treatment. Ensure you wear goggles.

Dedicated red light hair growth devices (such as laser caps designed for scalp use) are typically not shaped for eyebrow treatment and are not recommended for this purpose.

Realistic expectations

Based on the available evidence from scalp studies, here is what you can reasonably expect:

Possible benefits:

Increased density of existing eyebrow hairs (more hairs in anagen at any given time)
Slightly thicker individual hairs due to improved follicle health
Reduced shedding if thinning is related to telogen effluvium

Unlikely benefits:

Regrowth in areas where follicles have been permanently destroyed (scarring alopecia, deep burns)
Dramatic changes in eyebrow shape or arch — you are working with existing follicles
Rapid results — expect a minimum of three to four months before meaningful changes appear

Timeline: Hair follicles cycle slowly. Given the approximately four-month anagen phase for eyebrow hair, you should commit to at least four months of consistent treatment before judging effectiveness. Some users may notice reduced shedding within six to eight weeks.

The bottom line

Red light therapy for eyebrow growth is a biologically plausible intervention supported by indirect evidence from scalp hair growth research. The mechanisms — mitochondrial stimulation, improved blood flow, anti-inflammatory effects, and promotion of anagen entry — are not specific to scalp follicles and should theoretically apply to eyebrow hair.

However, there are no published clinical trials confirming this in practice. If you choose to try it, use 660nm light, protect your eyes rigorously, and commit to at least four months of consistent treatment before assessing results. Combine it with other evidence-based strategies — such as avoiding over-plucking and addressing any underlying thyroid or nutritional issues — for the best chance of success.

The risk is minimal. The cost is low if you already own a suitable device. But set your expectations accordingly: this is an area where the science is promising but unproven for the specific application.